These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2007181)

  • 1. Antiproliferative effects of oxygenated sterols: positive correlation with binding affinities for the antiestrogen-binding sites.
    Lin L; Hwang PL
    Biochim Biophys Acta; 1991 Mar; 1082(2):177-84. PubMed ID: 2007181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites.
    Hwang PL
    Biochim Biophys Acta; 1990 Feb; 1033(2):154-61. PubMed ID: 2306459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
    Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
    Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma cells selected for resistance against the cytotoxic effect of oxygenated sterols are also resistant to nonsteroidal antiestrogens.
    Low YL; Hwang PL
    Biochim Biophys Acta; 1995 Oct; 1269(1):32-40. PubMed ID: 7578268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
    Biswas R; Vonderhaar BK
    Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites.
    Ruenitz PC; Thompson CB; Srivatsan V
    J Steroid Biochem; 1989 Sep; 33(3):365-9. PubMed ID: 2550704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
    Teo CC; Kon OL; Sim KY; Ng SC
    J Med Chem; 1992 Apr; 35(8):1330-9. PubMed ID: 1573630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of sterols with antiestrogen-binding sites: structural requirements for high-affinity binding.
    Hwang PL; Matin A
    J Lipid Res; 1989 Feb; 30(2):239-45. PubMed ID: 2715728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic effect of antiestrogens in lymphoid cells: relationship to high affinity antiestrogen-binding sites and cholesterol.
    Tang BL; Teo CC; Sim KY; Ng ML; Kon OL
    Biochim Biophys Acta; 1989 Nov; 1014(2):162-72. PubMed ID: 2819087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells.
    Hoh YK; Lim EH; Ooi SO; Kon OL
    Experientia; 1990 Oct; 46(10):1032-7. PubMed ID: 2226718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
    Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
    Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
    Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
    Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.